Carfilzomib, dexamethasone and daratumumab in relapsed or refractory multiple myeloma: results of the phase III study CANDOR by prior lines of therapy
暂无分享,去创建一个
A. Nooka | Kihyun Kim | T. Facon | M. Mateos | S. Usmani | K. Weisel | Kenshi Suzuki | A. Spencer | C. Venner | A. Zahlten-Kumeli | S. Delimpasi | H. Quach | S. Grosicki | M. Obreja | O. Samoylova